title: Should antibiotics now be part of routine treatment of coronary heart disease?
authors.affiliation: Department of Cardiology, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. s.e.o.khogali@dundec.ac.uk
authors.forename: S E
authors.initials: SE
authors.lastname: Khogali
authors.forename: H S
authors.initials: HS
authors.lastname: Alyousuf
authors.forename: S T
authors.initials: ST
authors.lastname: Cheung
authors.forename: R E
authors.initials: RE
authors.lastname: Cameron
authors.forename: D
authors.initials: D
authors.lastname: Parratt
authors.forename: S D
authors.initials: SD
authors.lastname: Pringle
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*
chemical_list: D000900:Anti-Bacterial Agents